US 11603406
Antibodies binding to VISTA at acidic pH
granted A61KA61K39/39591A61P
Quick answer
US patent 11603406 (Antibodies binding to VISTA at acidic pH) held by Five Prime Therapeutics, Inc. expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Mar 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 39
- CPC classes
- A61K, A61K39/39591, A61P, A61P31/12, A61P35/00